Dyslipidaemia in patients with acute stroke at Da Nang C hospital, Vietnam
DOI:
https://doi.org/10.62992/pc6zbe38Keywords:
Acute stroke, Clinical characteristics, Risk factors, DyslipidemiaAbstract
Background: Stroke is a current medical issue in all countries worldwide. Currently, clinical characteristics and risk factors for developing acute stroke as well as dyslipidaemia have been identified.
Objectives: The research aimed to describe the status of dyslipidaemia in patients with acute stroke and the relationship between dyslipidaemia and certain clinical characteristics as also risk factors in patients with acute stroke at Da Nang C Hospital, Vietnam.
Methods: This retrospective cross-sectional study analysed 197 medical records of acute stroke patients at Da Nang C Hospital, Vietnam (February 2023-March 2024). Data collected included demographics (age, gender, height, weight), hypertension (systolic BP ≥140 mmHg, diastolic BP ≥90 mmHg), and lipid profiles (TC ≥5.2 mmol/L, triglycerides ≥1.7 mmol/L, LDL-C ≥3.4 mmol/L, HDL-C <0.9 mmol/L in males, <1.1 mmol/L in females). Statistical analyses were conducted using SPSS version 25.0 and Microsoft Excel 2016. Chi-square tests and odds ratios were calculated, with statistical significance set at P < 0.05.
Results: The percentage of dyslipidaemia in patients with stroke was 80.2%, with low HDL-C (52.3%) and high triglycerides (45.7%) being the most common abnormalities. Dyslipidaemia was more prevalent in the ischemic stroke group (98.1%) compared to the haemorrhagic stroke group with a 95% confidence interval (CI) of 1.26 – 27.58 (P-value = 0.030). The proportion of dyslipidaemia in stroke patients increases with age, with the highest rate observed in the 65-74 age group (38.4%). Stroke patients with dyslipidaemia also have a higher prevalence of hypertension (74.1%, 95% CI: 1.07 – 4.56), diabetes (41.1%, 95% CI: 1.04 – 5.23), and obesity (51.9%); with P-value 0.034, 0.043, and 0.860 respectively.
Conclusion: Patients with acute stroke often have dyslipidaemia, with the majority of cases characterized by decreased HDL-C levels and increased triglycerides. This tends to increase gradually with age.
References
Minh Hien N, Ngoc Anh T, Quoc Bao T. Cerebral Stroke. Hanoi: Medical Publishing House; 2013.
Ngoc TB. Study on clinical characteristics and risk factors of cerebral stroke over 50 year old patients. Journal of Science and Technology, Hoa Binh University. 2021(1):6113-8.
Truong Son N, Ngoc Khue L, Lan Viet N. Diagnosis and management guidelines for cerebral stroke. Hanoi, Vietnam: [Publisher Unknown]; 2020.
Thi HN. Metabolism and disorders of lipoprotein metabolism. In: Thanh Van T, Thi Ha N, Thi Ngoc Dung D, editors. Clinical Biochemistry. Hanoi, Vietnam: Nhà xuất bản Y học; 2015. p. 51-66.
Dinh CD, editor Study of some blood lipid indices in patients with stroke at the Friendship General Hospital in Nghe An province. Nghe An Medical Science Conference; 2015; Nghe An, Vietnam.
Tat TT, Thi TH. Characteristics of dyslipidemia in two groups of hypertensive and non‑hypertensive outpatients treated at Vinh City General Hospital. Vietnamese Medical Journal. 2022;520(1A):322-5.
Vietnam E, Diabetes A. Rối loạn chuyển hóa lipid máu [Dyslipidemia]. 2019.
Thanh HL, Thi Phuong N, Thi Kieu Trinh N. Assessment of nutritional status and some related factors in acute cerebral stroke patients with swallowing disorder at the Stroke Center – 108 Military Central Hospital. Journal of Nursing Science. 2023;6(03):102-8.
Van Bay H, Hong Phuc P, Van Yem H. Study on dyslipidemia in acute stroke patients at Military Hospital 120, Vietnam. Studocunet. 2014.
Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Spain; 2001.
Ministry of Health V. Guidance on diagnosis and treatment of obesity (Hướng dẫn chẩn đoán và điều trị bệnh béo phì) [Internet]. 2022.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-57.
Brutsaert EF. Diabetes Mellitus (DM). Merck Manual Professional Version. 2023.
Nirmala AC, Hrishikesh S. A cross sectional study of lipid profile in stroke patients. International Journal of Advances in Medicine. 2020;7(4):687-.
O'Donnell MJ, McQueen M, Sniderman A, Pare G, Wang X, Hankey GJ, et al. Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE). Journal of Stroke. 2022;24(2):224-35.
Ministry of Health V. Risk factors for stroke. 2021.
Thi Minh Thu H, Thi Ha N, Thi Phuong P. Survey on changes of some blood lipid indicators in geriatric patients with brain stroke at Nghe An Friendship General Hospital. Vietnam Medical Journal. 2023;530(1):290-3.
Thi Thanh Hang N, Thi Thuy Quynh T, Thi Thanh Tu N. The clinical and subclinical characteristics of ischemic stroke at the Geriatric Department of National Hospital of Traditional Medicine in 2022. Vietnam Medical Journal. 2024;543(1):342-5.
Ali IA, Mahmoud A, Anan A. The prevalence of dyslipidemia and hyperglycemia among stroke patients: preliminary findings. Stroke Research and Treatment. 2019;2019:1-8194960.
Afridi M, Farah R, Yasmin A. Association of dyslipidemia as a risk factor for the first episode of ischemic stroke. Journal of Postgraduate Medical Institute. 2023;37(2):119-24.
Vitturi BK, Gagliardi RJ. The prognostic significance of the lipid profile after an ischemic stroke. Neurological Research. 2021;44(2):139-45.
Ogbera AO, Oshinaike OO, Dada OD, Brodie‑Mends A, Ekpebegh C. Glucose and lipid assessment in patients with acute stroke. International Archives of Medicine. 2014;7:45-.
Yanai H, Yoshida H. Secondary dyslipidemia: its treatments and association with atherosclerosis. Global Health & Medicine. 2021;3(1):15-23.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
International Journal of Public Health Asia Pacific (IJPHAP) is licensed under a Creative Commons Attribution-Non-Commercial-No Derivatives 4.0 international (CC BY-NC-ND 4.0) license, unless otherwise stated. Please read our Policies page for more information on Open Access, copyright, and permissions.
